Game Over: FDA Warns Aventis For Repeat Use Of Taxotere Chess-Theme Ads

Aventis' chess-themed direct-to-consumer ads for the breast and lung cancer therapy Taxotere "misleadingly...imply that survival depends on treatment with Taxotere," FDA told the company in a warning letter